Novo Nordisk Recalls Insulin Diluting Medium Due to Temperature Abuse
Novo Nordisk Inc is recalling samples of Insulin Diluting Medium for NovoLog because storage below 32°F may cause lack of efficacy and damage to cartridges and pen-injectors.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class I, which indicates a reasonable probability that the use of the product will cause serious adverse health consequences or death. The rubric states that FDA Class I recalls must be scored at least 4.
Plain-English summary
Novo Nordisk Inc has initiated a voluntary recall of product samples identified as "Insulin Diluting Medium for NovoLog (Water Injection)". The affected items are NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), specifically one 10 mL multi-dose vials marked as samples and not for resale. The products were manufactured by Novo Nordisk A/S in Bagsvaerd, Denmark.
The recall is necessary because the product samples were stored at temperatures below 32°F, which violates required storage conditions. This temperature abuse could result in a lack of efficacy of the insulin diluting medium and cause physical damage to the cartridge and pen-injectors.
The recalled products are distributed nationwide within the USA. Affected lot numbers include JZFC826 with an expiration date of 06/30/2021, and KZFM305 with an expiration date of 08/31/2022. The FDA has classified this recall as Class I.
Consumers who possess these specific product samples should check their storage conditions and lot numbers. If the product was stored below freezing or shows signs of damage, it should not be used due to potential efficacy issues.
The recalled product
- Product
- INSULIN DILUTING MEDIUM FOR NOVOLOG (WATER INJECTION)
- Brand
- INSULIN DILUTING MEDIUM FOR NOVOLOG
- Manufacturer
- Novo Nordisk Inc
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- JZFC826 exp 06/30/2021
- KZFM305 exp 08/31/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by Novo Nordisk Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same brand · INSULIN DILUTING MEDIUM FOR NOVOLOG
- SevereNovo Nordisk Recalls Insulin Diluting Medium Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
Same manufacturer · Novo Nordisk Inc
See all →- HighWegovy 0.5 mg pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- HighWegovy prefilled pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- ModerateNovo Nordisk Recalls Saxenda Injection Samples Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls TRESIBA Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls Fiasp Insulin Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18